From: The protective effect of naringenin against pyrazinamide-induced hepatotoxicity in male Wistar rats
Parameter | Time (days) | Experimental group | Treatment effect | |||
---|---|---|---|---|---|---|
Control | PZA | PZA + NGN | NGN | |||
Glucose (mg dL−1) | 7 | 120.20 ± 1.54a | 118.70 ± 2.64a | 119.54 ± 0.42a | 118.40 ± 2.67a | F3, 16 = 0.161, P = 0.921 |
14 | 120.24 ± 1.13a | 120.70 ± 1.44a | 120.28 ± 1.00a | 120.02 ± 0.92a | F3, 16 = 0.062, P = 0.979 | |
21 | 121.58 ± 0.91a | 127.30 ± 1.62b* | 121.98 ± 0.91a | 121.42 ± 1.02a | F3, 16 = 6.021, P = 0.006 | |
28 | 123.04 ± 1.21a | 132.26 ± 2.45b* | 121.60 ± 1.01a | 122.18 ± 1.02a | F3, 16 = 10.59, P = 0.000 | |
r | – | + 0.77 | + 0.44 | + 0.41 | ||
Time effect | F3, 16 = 1.217, P = 0.336 | F3, 16 = 8.756, P = 0.001 | F3, 16 = 1.714, P = 0.204 | F3, 16 = 1.099, P = 0.378 | ||
TBIL (mg dL−1) | 7 | 0.67 ± 0.01a | 0.68 ± 0.02a | 0.66 ± 0.01a | 0.69 ± 0.03a | F3, 16 = 0.554, P = 0.653 |
14 | 0.68 ± 0.01a | 0.74 ± 0.04a | 0.69 ± 0.04a | 0.67 ± 0.03a | F3, 16 = 0.787, P = 0.519 | |
21 | 0.68 ± 0.01a | 0.80 ± 0.02b* | 0.70 ± 0.02a | 0.68 ± 0.02a | F3, 16 = 13.14, P = 0.000 | |
28 | 0.69 ± 0.01a | 0.83 ± 0.01b* | 0.69 ± 0.02a | 0.68 ± 0.03a | F3, 16 = 16.32, P = 0.000 | |
r | – | + 0.75 | + 0.27 | − 0.06 | ||
Time effect | F3, 16 = 0.764, P = 0.531 | F3, 16 = 7.267, P = 0.003 | F3, 16 = 0.681, P = 0.577 | F3, 16 = 0.061, P = 0.98 | ||
IBIL (mg dL−1) | 7 | 0.57 ± 0.01a | 0.58 ± 0.01a | 0.55 ± 0.01a | 0.58 ± 0.03a | F3, 16 = 0.397, P = 0.757 |
14 | 0.58 ± 0.01a | 0.63 ± 0.04a | 0.59 ± 0.03a | 0.57 ± 0.04a | F3, 16 = 0.598, P = 0.626 | |
21 | 0.58 ± 0.02a | 0.69 ± 0.01b* | 0.59 ± 0.01a | 0.58 ± 0.01a | F3, 16 = 12.37, P = 0.000 | |
28 | 0.59 ± 0.01a | 0.71 ± 0.02b* | 0.59 ± 0.02a | 0.58 ± 0.02a | F3, 16 = 12.98, P = 0.000 | |
r | – | + 0.70 | + 0.25 | − 0.02 | ||
Time effect | F3, 16 = 0.518, P = 0.676 | F3, 16 = 5.381, P = 0.009 | F3, 16 = 0.694, P = 0.569 | F3, 16 = 0.023, P = 0.995 | ||
ASAT (U/mL) | 7 | 34.50 ± 1.15a | 35.60 ± 1.23a | 34.10 ± 0.79a | 33.68 ± 0.82a | F3, 16 = 0.657, P = 0.59 |
14 | 36.10 ± 0.94a | 37.72 ± 1.37a | 36.58 ± 1.01a | 35.30 ± 1.28a | F3, 16 = 0.76, P = 0.533 | |
21 | 32.60 ± 1.08a | 46.32 ± 1.52b* | 35.60 ± 1.30a | 33.10 ± 1.12a | F3, 16 = 25.55, P = 0.000 | |
28 | 34.92 ± 1.17a | 55.26 ± 1.29b* | 33.52 ± 1.29a | 34.00 ± 1.76a | F3, 16 = 57.56, P = 0.000 | |
r | – | + 0.92 | − 0.12 | − 0.05 | ||
Time effect | F3, 16 = 1.797, P = 0.188 | F3, 16 = 43.78, P = 0.000 | F3, 16 = 1.558, P = 0.238 | F3, 16 = 0.521, P = 0.674 | ||
ALAT (U/mL) | 7 | 25.80 ± 0.39a | 25.38 ± 1.18a | 25.16 ± 1.09a | 25.18 ± 1.41a | F3, 16 = 0.075, P = 0.973 |
14 | 24.16 ± 0.69a | 29.00 ± 2.12a | 25.42 ± 1.38a | 22.68 ± 1.16a | F3, 16 = 1.768, P = 0.194 | |
21 | 24.76 ± 0.65a | 38.28 ± 1.28b* | 24.64 ± 1.42a | 23.80 ± 1.37a | F3, 16 = 32.49, P = 0.000 | |
28 | 25.86 ± 1.32a | 41.22 ± 0.72b* | 26.82 ± 1.29a | 23.94 ± 1.15a | F3, 16 = 47.89, P = 0.000 | |
r | – | + 0.90 | + 0.17 | − 0.11 | ||
Time effect | F3, 16 = 0.984, P = 0.425 | F3, 16 = 46.03, P = 0.000 | F3, 16 = 0.512, P = 0.68 | F3, 16 = 0.643, P = 0.598 |